Healthy choices
make a difference

Discover more
Research
September 16, 2020

NAFLD/NASH and Diabetes

Research
September 16, 2020

Fatty Liver

Research
September 16, 2020

Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.

Research
September 16, 2020

Pigs Grow New Liver in Lymph Nodes, Study Shows

Research
September 8, 2020

Diagnosed with Fatty Liver Disease?

Research
September 8, 2020

Diagnosed with Fatty Liver Disease?

Covid-19News
July 1, 2020

COVID-19 updates

Covid-19News
July 1, 2020

Howe does COVID-19 affect liver patients

Covid-19Links & Resources
May 12, 2020

Chronic Liver Disease and Coronavirus

Covid-19
May 4, 2020

COVID-19 and Chronic Liver Disease – WebMd

More than 4 in 5 people who have symptoms of COVID-19, the illness caused by the new coronavirus, get only mildly sick. But if you have ongoing health issues, including…
Covid-19Research
May 4, 2020

FierceBiotech – Akero’s NASH drug cuts liver fat in phase 2, but COVID-19 may delay full data

ArticlesCovid-19
May 4, 2020

Stay informed from reliable sources

Research
September 16, 2020

NAFLD/NASH and Diabetes

Research
September 16, 2020

Fatty Liver

Research
September 16, 2020

Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S.

Research
September 16, 2020

Pigs Grow New Liver in Lymph Nodes, Study Shows

Research
September 8, 2020

Diagnosed with Fatty Liver Disease?

Research
September 8, 2020

Diagnosed with Fatty Liver Disease?

Research
September 8, 2020

Nonalcoholic Fatty Liver Disease

Research
September 8, 2020

EASL Clinical Practice Guidelines on nutrition in chronic liver disease

Research
August 10, 2020

Nash Warnings – NAFLD

Research
August 10, 2020

NASH (nonalcoholic steatohepatitis), diabetes, and macrovascular disease

Research
June 29, 2020

NASH Has Gone Under the Radar, but It Is the _Elephant in the Room,_ Panelists Say

ArticlesResearch
May 24, 2020

Nutrition Action diabetes article

Research
May 17, 2020

Genfit’s elafibranor en route to NASH graveyard with phase 3 flop

Research
May 5, 2020

Common myths about cirrhosis

Covid-19Research
May 4, 2020

FierceBiotech – Akero’s NASH drug cuts liver fat in phase 2, but COVID-19 may delay full data

Research
May 4, 2020

India wins the dash for NASH, as Zydus Cadila’s saroglitazar wins first approval

Lifestyle Matters!
June 29, 2020

Why do we need a NASH drug? NASH leaders weigh in

Lifestyle Matters!
June 29, 2020

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way

Lifestyle Matters!
June 15, 2020

Gluten & Meat Substitutes

Lifestyle Matters!Links & Resources
May 12, 2020

The Role of the Toxic Food Environment in the Obesity Epidemic

Lifestyle Matters!
May 5, 2020

Vital Organs – Ami Magazine

Lifestyle Matters!
May 5, 2020

Eating, Diet, & Nutrition for NAFLD & NASH

how it started

I Love My Liver Team

“I Love My Liver Team” was created by Phyllis Miller and printed on canvas tote bags distributed to the team of doctors, nurses, researchers, hospital staff, science teachers, and support staff, friends and family, who supported her husband, David, during his struggles with NASH. While he did not survive the liver transplant (which was the only option by the time he was diagnosed with stage 4 fibrosis), Phyllis decided to use her experience to educate others about NASH so they could take action before it was too late.

NASH is quickly outpacing alcoholic related cirrhosis and despite ongoing research and drug trials, lifestyle modification is currently the only viable option for this metabolic disease. Note from Phyllis: “I am not a doctor or a medical professional, and everyone’s first step should be to consult with your doctor and develop a plan of action, if you suspect you may be on the NASH path.” While various tests determine “fatty liver” or reveal irregular liver enzymes (ALT or ALP), the Fibro Scan and conclusive biopsy are not always called into play during early stages of the disease.
This website is designed to create awareness about NASH.

how it started

I Love My Liver Team

“I Love My Liver Team” was created by Phyllis Miller and printed on canvas tote bags distributed to the team of doctors, nurses, researchers, hospital staff, science teachers, and support staff, friends and family, who supported her husband, David, during his struggles with NASH. While he did not survive the liver transplant (which was the only option by the time he was diagnosed with stage 4 fibrosis), Phyllis decided to use her experience to educate others about NASH so they could take action before it was too late.

NASH is quickly outpacing alcoholic related cirrhosis and despite ongoing research and drug trials, lifestyle modification is currently the only viable option for this metabolic disease. Note from Phyllis: “I am not a doctor or a medical professional, and everyone’s first step should be to consult with your doctor and develop a plan of action, if you suspect you may be on the NASH path.” While various tests determine “fatty liver” or reveal irregular liver enzymes (ALT or ALP), the Fibro Scan and conclusive biopsy are not always called into play during early stages of the disease.
This website is designed to create awareness about NASH.

Want to formulate an awareness program in your community?